Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. [electronic resource]
Producer: 20121116Description: 36-46 p. digitalISSN:- 1365-2249
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- immunology
- B-Lymphocytes -- drug effects
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Case-Control Studies
- Disease Progression
- Drug Therapy, Combination
- Female
- Flow Cytometry
- GPI-Linked Proteins -- immunology
- Granulocytes -- drug effects
- Humans
- Infliximab
- Leukocyte Count
- Leukocytes -- drug effects
- Lipopolysaccharide Receptors -- immunology
- Male
- Methotrexate -- administration & dosage
- Methylprednisolone -- therapeutic use
- Middle Aged
- Monocytes -- drug effects
- Receptors, IgG -- immunology
- Tumor Necrosis Factor-alpha -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.